15-Year watch begins for MB-105 patients
NCT ID NCT07340814
First seen Jan 15, 2026 · Last updated May 02, 2026 · Updated 22 times
Summary
This study follows about 40 people who have already received the experimental treatment MB-105. Researchers will check for serious side effects and track how long the treatment's effects last over 15 years. No new treatment is given—this is a long-term safety and effectiveness check required by regulators.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANY PATIENT TREATED WITH MB-105 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.